Dr Lal Path­labs

Dalal Street Investment Journal - - COVER STORY -

Dr Lal Path­labs is one of the renowned di­ag­nos­tic health­care ser­vices com­pa­nies in In­dia. The com­pany has an in­creas­ing pres­ence with an al­ready es­tab­lished wide net­work of di­ag­nos­tic health­care cen­tres. The com­pany of­fers over 3,368 di­ag­nos­tic and re­lated health­care tests and ser­vices pre­scribed by physi­cians in In­dia. The com­pany has a qual­i­fied team of 147 pathol­o­gists, 8 ra­di­ol­o­gists, 13 mi­cro­bi­ol­o­gists, 5 bio­chemists as well as 11 spe­cial­ists.

The com­pany has a grow­ing pres­ence across In­dia and also op­er­ates labs and di­ag­nos­tic cen­tres in Saudi Ara­bia, UAE, Nige­ria, Bangladesh and Sri Lanka, among oth­ers. Since April 2016, the com­pany has set up 17 new labs, 200 PSCS and about 5021 ac­tive pick-up points in the coun­try. The com­pany’s labs un­der hospi­tal lab man­age­ment con­tracts have in­creased to 22 in the cur­rent fis­cal.

On the fi­nan­cial front, Dr Lal Path Labs wit­nessed a 12.10 per cent in­crease in its net sales to ₹241.80 crore in the first quar­ter of FY18 on a year-on-year ba­sis. The PBIDT of the com­pany grew 8.73 per cent to ₹63.50 crore in Q1FY18 as against ₹58.40 crore in Q1FY17. The profit af­ter tax of the com­pany in­creased 11.37 per cent to ₹43.10 crore in the first quar­ter of FY18 as against ₹38.70 crore in the first quar­ter of the pre­vi­ous fis­cal.

On an an­nual ba­sis, Dr Lal Path Labs wit­nessed a rise of 15.22 per cent in its net sales to ₹881.87 crore in FY17 as against ₹765.40 crore in FY16. The PBIDT of the com­pany grew 12.38 per cent to ₹229.09 crore in FY17 as against ₹203.85 crore in FY16. The profit af­ter tax of the com­pany in­creased 17.06 per cent to ₹147.21 crore in FY17 as against ₹125.76 crore in the pre­vi­ous fis­cal.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.